// App-Quantinova.ai

P576 : Impact of improved access to biologic therapies and physician engagement on excess steroid exposure: Results from a UK audit of 3561 patients

Researchers

Presenter

  • C Selinger

Principal Investigators

  • M Adamson

  • A Bassi

  • F Donovan

  • A Fraser

  • B George

  • L Grey

  • V Hall

  • J Lindi

  • H Ludlow

  • I Parisi

  • P Patel

  • R Pollock

  • S Salunke

  • J Saunders

  • G Scott

  • M Smith

  • T Raine

Medical Centers

  • Leeds Teaching Hospital Trust, Leeds, UK

  • Royal London Hospital, Barts Health NHS Trust, London, UK

  • Salisbury NHS Foundation Trust Hospital, Salisbury, UK

  • St Helens and Knowsley Foundation Trust, St Helens, UK

  • Kingston Hospital NHS Foundation Trust, Kingston, United Kingdom

  • Bristol Royal Infirmary, Bristol, UK

  • Torbay and South Devon NHS Trust, Torbay, UK

  • Wirral University Teaching Hospital, Birkenhead, UK

  • Royal Bolton Hospital, Bolton, UK

  • North Manchester General Hospital, Manchester, United Kingdom

  • University Hospital Llandough, Cardiff, UK

  • University College Hospital, London,

  • Epsom and St Helier University Hospitals NHS Trust, Epsom, United Kingdom

  • St Georges University Hospitals NHS Foundation Trust, London, UK

  • Forth Valley Royal Hospital, Falkirk, UK

  • Rheumatology, Royal United Hospitals Bath NHS Foundation Trust, Bath, UNITED KINGDOM

  • East Kent Hospitals University NHS Foundation Trust, Margate, UK

  • Brighton and Sussex University Hospitals NHS Trust, Sussex Cancer Centre, Brighton, United Kingdom

  • Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved